Malignant Tumors
Oncology
3
Pipeline Programs
1
Companies
3
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
3
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
LaNova MedicinesChina - Shanghai
3 programs3
LM-299Phase 1/21 trial
LM-350 for injectionPhase 1/21 trial
LM101Phase 1/21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
LaNova MedicinesLM-350 for injection
LaNova MedicinesLM-299
LaNova MedicinesLM101
Clinical Trials (3)
A Study of LM-350 in Subjects With Advanced Solid Tumours
Start: Aug 2025Est. completion: Jun 2030
Phase 1/2Recruiting
Study of LM-299 in Subjects Advanced Malignant Tumors
Start: Oct 2024Est. completion: Jul 2027
Phase 1/2Recruiting
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
Start: Jan 2023Est. completion: Jan 2028
Phase 1/2Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
3h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
3h ago
Office Administrator
SystImmune
3h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
3h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
3h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
3h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials
1 companies competing in this space